12 min listen
Fluticasone, Umeclidinium, and Vilanterol Pharmacology
FromReal Life Pharmacology - Pharmacology Education for Health Care Professionals
Fluticasone, Umeclidinium, and Vilanterol Pharmacology
FromReal Life Pharmacology - Pharmacology Education for Health Care Professionals
ratings:
Length:
12 minutes
Released:
Apr 23, 2020
Format:
Podcast episode
Description
Fluticasone, Umeclidinium, and Vilanterol is a combination medication used in the setting of COPD. I discuss the pharmacology of this agent further in this episode.
Fluticasone is the inhaled corticosteroid portion of the drug while umeclidinium is a LAMA and vilanterol is a LABA medication.
Drug interactions aren't incredibly common or strongly clinically significant, but I discuss some of them with Trelegy Ellipta.
Having a once-daily dose can be advantageous to help improve patient adherence. Fluticasone, umeclidinium, and vilanterol comes as a once-daily combination.
Fluticasone is the inhaled corticosteroid portion of the drug while umeclidinium is a LAMA and vilanterol is a LABA medication.
Drug interactions aren't incredibly common or strongly clinically significant, but I discuss some of them with Trelegy Ellipta.
Having a once-daily dose can be advantageous to help improve patient adherence. Fluticasone, umeclidinium, and vilanterol comes as a once-daily combination.
Released:
Apr 23, 2020
Format:
Podcast episode
Titles in the series (100)
NSAID Pharmacology RLP Episode 008: In this podcast episode I discuss the pharmacology of NSAIDs and the potential collateral damage that can result from these medications. We'll cover: Side effects Mechanism of Action Important Drug Interactions by Real Life Pharmacology - Pharmacology Education for Health Care Professionals